Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

These 9 Stocks Are Running To Start 2024

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Investors Business Daily

60% Of This Year's Top Stocks Are In This Sector (It's Not Tech)

Just when it looked like technology stocks took over the S&P 500 — another sector is on the rise.

Investors Business Daily

Iron Condor Alert: LLY Stock Could Net 40% In 4 Weeks

Eli Lilly (LLY) is showing elevated implied volatility with an IV Percentile of 98%, and that could mean it’s a good time for an iron condor trade.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Hot Biotech Play Breaks Out Into By Range

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.

Investors Business Daily

Alphabet's Isomorphic Labs In Drug Discovery Deals With Eli Lilly, Novartis

Alphabet unit Isomorphic Labs, which uses AI to help discover new drugs, entered collaboration deals with Eli Lilly and Novartis.

Investors Business Daily

Will weight loss drugs kill the fast food business?

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite counts’

The Guardian - UK

Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes; Can Market Rally Hold Key Levels?

Dow Jones futures fell as the FAA grounded many Boeing 737 Max-9 jets after a midair incident on Friday. Can the market rally hold key levels?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze

Novo Nordisk stock is Friday's IBD Stock Of The Day. Shares are in a buy zone after the firm inked deals in the weight-loss drugs space.

Investors Business Daily

Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review

The S&P 500 snapped a nine-week win streak, but tried to find support. Tesla, Apple and Mobileye were key losers.

Investors Business Daily

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

Biotech stocks are heating up as multibillion-dollar deals pile up and new modalities like CRISPR gene-editing hit prime time.

Investors Business Daily

11 Stocks Are Taking Off Already — And The Year Just Started

The calendar just flipped to 2024 — and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated.

Investors Business Daily

Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound

The Independent UK

Eli Lilly Launches Unique Website Connecting Patients to Obesity Care+

Eli Lilly launches LillyDirect, a one-of-a-kind website connecting patients seeking obesity treatment to doctors and its weight-loss drug. Streamlining hea...

Top News

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of diabetes and obesity

The news comes as rampant demand for the reputed “miracle drugs” leads to nationwide shortages.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom

The major indexes held up Thursday with bullish action from many leading stocks. The December jobs report and spot Bitcoin ETF approvals loom.

Barchart

Eli Lilly Stock: Buy or Sell?

Eli Lilly's diversified portfolio and high demand for its weight-loss drugs have pushed it to the top of Wall Street's list of top pharma stocks for 2024. Is now the time to buy?

Investors Business Daily

Eli Lilly Beefs Up Its Weight-Loss Marketing Efforts With New Direct-To-Consumer Site

Eli Lilly stepped up its marketing efforts for weight-loss drugs Thursday, launching a new website. Eli Lilly stock fell a fraction.

Investors Business Daily

Dow Jones Futures Rise After Market Losses; Cathie Wood Buys Tesla, Sells Bitcoin Stock Coinbase

The Nasdaq extended a losing streak. Cathie Wood bought Tesla stock and sold Bitcoin stock Coinbase.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Investors Business Daily

Dow Jones Futures Fall After Techs Skid To Start 2024; Celsius, Eli Lilly Flash Buy Signals

Big tech winners led Tuesday's skid. Weight loss plays Celsius and Eli Lilly flashed buy signals. Tesla and Microsoft held up.

Investors Business Daily

Eli Lilly, IBD Stock Of The Day, Strikes Bullish Pose After Closing A Key Buyout

Eli Lilly stock is Tuesday's IBD Stock Of The Day after the company wrapped its $1.4 billion takeover of Point Biopharma.

Investors Business Daily

Dow Jones Futures Fall To Start 2024; Tesla Deliveries Due As Rival Races Ahead

After a big 2023, the market rally looks strong heading into 2024. Tesla deliveries are due after key rivals reported.

Investors Business Daily

Which Mutual Funds Are Positioned Perfectly For 2024?

Positive economic events set a bullish storyline for investors in the best mutual funds in 2023.

Investors Business Daily

Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?

AMPH stock has doubled so far this year and is in a buy zone again. It earlier bought Eli Lilly's emergency diabetes drug which can drive future growth.

Investors Business Daily

Structure Plummets 43% After Trailing Lilly In Obesity Treatment

Structure's potential rival to Lilly in weight-loss drugs missed expectations on Monday, and GPCR stock took an absolute beating.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.